BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 27
• 28

• Pharm Country

  Tela Bio Private Stock Sale Brings it $16 Million

  December 7, 2012

   · 

  1 min read
• BioMidwest

  BioDrain Medical, Inc. Lands Key Accounts in Minnesota and Michigan Expanding Its U.S. Market Share

  December 7, 2012

   · 

  3 min read
• Drug Development

  PROLOR Biotech to Present Preclinical Data on Its Long-Acting Clotting Factor Vlla at 2012 American Society of Hematology Annual Meeting

  December 7, 2012

   · 

  5 min read
• Drug Development

  Isis Pharmaceuticals, Inc. Reports Positive Phase 1 Data on Three Drugs in Development to Treat Metabolic Disorders

  December 7, 2012

   · 

  6 min read
• Deals

  Winner Medical Group Stockholders Vote to Approve Merger

  December 7, 2012

   · 

  2 min read
• IntelGenx Corp. Grants Stock Options

  December 7, 2012

   · 

  1 min read
• Drug Development

  FDA Grants Orphan Drug Designation to Biodel Inc.l’s Glucagon for Prevention of Hypoglycemia in Congenital Hyperinsulinism Population

  December 7, 2012

   · 

  1 min read
• Drug Development

  Capstone Therapeutics Release: Apolipoprotein E Mimetic Peptide AEM-28 Granted Orphan Drug Designation for the Treatment of Homozygous Familial Hypercholesterolemia

  December 7, 2012

   · 

  1 min read
• Drug Development

  TG Therapeutics, Inc. Initiates a Phase I/II Clinical Trial of Its Novel Third-Generation Anti-CD20 Monoclonal Antibody, TG-1101 (Ublituximab), in Combination With Lenalidomide (Revlimid®) in Patients With B-Cell Lymphoid Malignancies

  December 7, 2012

   · 

  1 min read
• Business

  Professional Baseball Strength and Conditioning Coordinator Kevin Barr Joins Fuse Science, Inc. Advisory Board

  December 7, 2012

   · 

  3 min read